➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Harvard Business School
Merck
Moodys
AstraZeneca

Last Updated: January 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DS-5565

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Clinical Trials for DS-5565

Trial ID Title Status Sponsor Phase Summary
NCT01496365 Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Completed Daiichi Sankyo Inc. Phase 2 The purpose of this study is to evaluate the safety, tolerability and effectiveness of DS-5565 compared to placebo (inactive substance) and pregabalin in diabetic subjects with DPN.
NCT01504412 Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuorpathy Completed Daiichi Sankyo Co., Ltd. Phase 2 The purpose of this study is to investigate the effectiveness and safety of DS-5565, compared to placebo, in subjects with pain associated with diabetic peripheral neuropathy.
NCT02146430 Treatment of Pain Associated With Fibromyalgia Active, not recruiting INC Research Phase 3 DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02146430 Treatment of Pain Associated With Fibromyalgia Active, not recruiting Daiichi Sankyo Inc. Phase 3 DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02187159 Treatment of Pain Associated With Fibromyalgia Active, not recruiting INC Research Phase 3 DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02187159 Treatment of Pain Associated With Fibromyalgia Active, not recruiting Daiichi Sankyo Inc. Phase 3 DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02187471 Treatment of Pain Associated With Fibromyalgia Active, not recruiting INC Research Phase 3 DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for DS-5565

Condition Name

Condition Name for
Intervention Trials
Pain Associated With Fibromyalgia 4
Diabetic Peripheral Neuropathic Pain 3
Post-herpetic Neuralgia 2
Diabetic Peripheral Neuropathy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for
Intervention Trials
Neuralgia 6
Diabetic Neuropathies 5
Myofascial Pain Syndromes 5
Fibromyalgia 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for DS-5565

Trials by Country

Trials by Country for
Location Trials
United States 166
United Kingdom 29
Canada 10
Australia 10
France 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for
Location Trials
Florida 6
Arizona 6
Texas 6
Tennessee 6
South Carolina 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for DS-5565

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 10
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Active, not recruiting 6
Recruiting 3
Completed 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for DS-5565

Sponsor Name

Sponsor Name for
Sponsor Trials
Daiichi Sankyo Co., Ltd. 6
Daiichi Sankyo Inc. 6
INC Research 4
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 17
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
Moodys
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.